stereoisomerism

Preferred Label : stereoisomerism;

MeSH definition : The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed);

Related MeSH term : molecular stereochemistry; stereoisomers; Stereochemistry, Molecular; Stereoisomer;

MeSH annotation : NIM; policy: Manual 25.5.5.1;

Wikipedia link : https://en.wikipedia.org/wiki/Stereoisomer;

Details

Origin ID

D013237;

UMLS CUI

C0038265;

Automatic exact mappings (from CISMeF team)
- stereoisomerism [IUPAC Term]
- stereoisomers [IUPAC Term]
Indexing information
- (+)-(7R,8R)-4-hydroxy-3,3',5'-trimethoxy-8',9'-dinor-8,4'-oxyneoligna-7,9-diol-7'-aldehyde [MeSH Supplementary Concept]
- (+)-N-deoxymilitarinone A [MeSH Supplementary Concept]
- (1S,4S,5S)-5-exo-hydroxycamphor 5-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (25R)-22-O-methyl-furost-5-en-3beta,26-diol-3-O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (25S)-26-O-beta-D-glucopyranosyl-furost-1beta,3beta,5beta,22alpha, 26-pentaol-3-O-beta-D-glucoside [MeSH Supplementary Concept]
- (2R)-7-methoxyl-8-hydroxyethyl-4'-hydroxylflavane-2'-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (2S,3S)-sulfated pterosin C [MeSH Supplementary Concept]
- (5S(*),6R(*),7S(*))-5,6,7-trihydroxy-2-(3-hydroxy-4-methoxyphenethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one [MeSH Supplementary Concept]
- (6E,12Z)-tetradecadiene-8,10-diyne-1,3-diol [MeSH Supplementary Concept]
- (6R,7S,11R,10S)-15-hydroxy-sesquisabinene hydrate [MeSH Supplementary Concept]
- (6Z,8E)-undeca-6,8,10-trien-4-one [MeSH Supplementary Concept]
- (E)-geranylferulic acid [MeSH Supplementary Concept]
- (M)-bicelaphanol A [MeSH Supplementary Concept]
- (S)-(+)-4'-O-angeloyl-5-O-methylvisamminol [MeSH Supplementary Concept]
- (S)-(+)-4'-O-senecioyl-5-O-methylvisamminol [MeSH Supplementary Concept]
- (chloromethyldimethylsilyl)-2-propenyl acetate [MeSH Supplementary Concept]
- 1,2-dibromo-1-(2-methoxymethoxyethyl)cyclopropane [MeSH Supplementary Concept]
- 1,4-di-(4-hydroxyphenyl)-2,3-butanediol [MeSH Supplementary Concept]
- 1-(3,4-dichlorophenyl)-3-azabicyclo-(3.1.0)hexane hydrochloride [MeSH Supplementary Concept]
- 1-(3,4-dihydroxyphenyl)-2-(3-(4-carbamylphenyl)-1-methylpropylamino)ethanol [MeSH Supplementary Concept]
- 1-(4-methyl-5-thiazolyl)-1-phenylmethylamine [MeSH Supplementary Concept]
- 1-(6-aminopurin-9-yl)-2-(hydroxymethyl)cyclopentane triphosphate [MeSH Supplementary Concept]
- 1-(9-adenyl)cyclopentan-3-ol [MeSH Supplementary Concept]
- 1-amino-1,3-dicarboxycyclopentane [MeSH Supplementary Concept]
- 1-amino-2-hydroxypropane phosphonic acid [MeSH Supplementary Concept]
- 1-amino-3-(methylthio)propylphosphinic acid [MeSH Supplementary Concept]
- 1-aminocyclopentane-1,3,4-tricarboxylic acid [MeSH Supplementary Concept]
- 1-oxa-2-azaspiro(4.5)dec-2-ene-8alpha-ol [MeSH Supplementary Concept]
- 10-hydroxyasimicin [MeSH Supplementary Concept]
- 10-hydroxyphthoxazolin A [MeSH Supplementary Concept]
- 11,13-dihydroxanthatin [MeSH Supplementary Concept]
- 11,17-dideoxyagelorin A [MeSH Supplementary Concept]
- 11-alpha-methoxycurvularin [MeSH Supplementary Concept]
- 11-gorgiacerol [MeSH Supplementary Concept]
- 11alpha H-6 beta-angeloyloxy-15-carboxyeremophil-7-en-12,8-olide [MeSH Supplementary Concept]
- 12-hydroxysophocarpine [MeSH Supplementary Concept]
- 13-epi-preleoheterin [MeSH Supplementary Concept]
- 14 beta-cholest-5-en-3 beta-ol [MeSH Supplementary Concept]
- 14-deoxy-9-oxygigantecin [MeSH Supplementary Concept]
- 14beta-hydroperoxy-eburnamine [MeSH Supplementary Concept]
- 15beta-methoxyfaciculatin [MeSH Supplementary Concept]
- 16,17-cyclohexano-4,5-dihydroprogesterone [MeSH Supplementary Concept]
- 16-hydroxymethyl-5-androstane-3,17-diol [MeSH Supplementary Concept]
- 1beta,2beta-epoxy-10(H)alpha-dauca-11(12)-ene-7alpha,14-diol [MeSH Supplementary Concept]
- 2,10-diacetyl-5(Z)-cinnamoylphototaxicin II [MeSH Supplementary Concept]
- 2,3-dihydroxy-1,3,5(10),8-tetra-ene-6-(2'-hydroxyethyl)-24-nor-D-A-friedooleanane-29-oic acid [MeSH Supplementary Concept]
- 2,3-isopropylidenedioxy-6,6-ethylenedioxy-5alpha-androst-15-en-17-one [MeSH Supplementary Concept]
- 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-(1)benzopyrano(3,4-f)quinoline [MeSH Supplementary Concept]
- 2-(2-carboxy-3,3-difluorocyclopropyl)glycine [MeSH Supplementary Concept]
- 2-(4-carboxy-5-methylene-2H-thiazol-2-yl)-3-hydroxybutanoic acid [MeSH Supplementary Concept]
- 2-(5-fluorouracil-1-yl)-5-hydroxymethyl-3-(uracil-1-yl)-1,4-dioxane [MeSH Supplementary Concept]
- 2-(methoxycarbonyl)-7-methyl-3-phenyl-7-azabicyclo(2.1.1)heptane [MeSH Supplementary Concept]
- 2-Fu-AMPA [MeSH Supplementary Concept]
- 2-bromomethyl-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl [MeSH Supplementary Concept]
- 2-chloro-1-epicalcitriol [MeSH Supplementary Concept]
- 2-chloro-9-(2-deoxy-2-fluororibofuranosyl)adenine [MeSH Supplementary Concept]
- 2-dodecenoic acid [MeSH Supplementary Concept]
- 2-fluoro-19-nor-1,25-dihydroxyvitamin D3 [MeSH Supplementary Concept]
- 2-hydroxymethyl-3-methylcyclopent-2-enone [MeSH Supplementary Concept]
- 2-thionosparteine [MeSH Supplementary Concept]
- 22-ethyl-1,25-dihydroxy-23,24-didehydro-24a,24b-dihomo-20-epivitamin D(3) [MeSH Supplementary Concept]
- 28-norlup-20(29)-en-3beta-hydroxy-17beta-hydroperoxide [MeSH Supplementary Concept]
- 2alpha,3beta,19alpha-trihydroxy-28-norurs-12-ene [MeSH Supplementary Concept]
- 2beta,3beta,19alpha,24-tetrahydroxyurs-12-en-28-oic acid [MeSH Supplementary Concept]
- 3'-epidaunorubicin [MeSH Supplementary Concept]
- 3,7,12-trihydroxycholestan-27-oic acid [MeSH Supplementary Concept]
- 3-(2-methoxybenzylamino)-2-phenylpiperidine [MeSH Supplementary Concept]
- 3-chlorimperialine [MeSH Supplementary Concept]
- 3-hydroxy-13-methyltetradecanoic acid [MeSH Supplementary Concept]
- 3-nitrobenzenesulfonic acid [MeSH Supplementary Concept]
- 3-pentyn-2-ol [MeSH Supplementary Concept]
- 3R-(3,4-dimethoxyphenyl)-4S-((E)-3,4-dimethoxystyryl)cyclohex-1-ene [MeSH Supplementary Concept]
- 3alpha, 24-dihydroxyurs-12-ene [MeSH Supplementary Concept]
- 3alpha-hydroxy chlormadinone acetate [MeSH Supplementary Concept]
- 3beta,8alpha-dihydroxy-13-methoxyl-4(14),10(15)-dien-(1alphaH,5alphaH,6beta H,11betaH)-12,6-olide [MeSH Supplementary Concept]
- 3beta-OH-tibolone [MeSH Supplementary Concept]
- 4,4'-diprolylamine [MeSH Supplementary Concept]
- 4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole [MeSH Supplementary Concept]
- 4-(6-cyclohexylhex-3-enyl)imidazole [MeSH Supplementary Concept]
- 4-amino-7-guanidino-2,3-dihydroxyheptanoic acid [MeSH Supplementary Concept]
- 4-chlorobenzyltetrahydroberberine [MeSH Supplementary Concept]
- 4-oxo-4-(2-pyridinylamino)butanoic acid [MeSH Supplementary Concept]
- 4-thiocyanatoneopupukeanane [MeSH Supplementary Concept]
- 5,6-O-methylaconitic acid [MeSH Supplementary Concept]
- 5,6-epoxy-3-dehydroretinal [MeSH Supplementary Concept]
- 5,8-dihydroxy-5,6,7,8-tetrahydro-1,4-naphthoquinone [MeSH Supplementary Concept]
- 5-(2-(methyl(2-phenethyl)amino)-2-oxoethyl)-2-(benzyloxy)cinnamic acid [MeSH Supplementary Concept]
- 5-methyl-8-hydroxy-2-(di-n-propylamino)tetralin [MeSH Supplementary Concept]
- 5-phenylpentylglutamic acid [MeSH Supplementary Concept]
- 5alpha-hydroxyl-1beta-bisabolon-9-one [MeSH Supplementary Concept]
- 6,6-dicarboxy-3,4-methano-L-proline [MeSH Supplementary Concept]
- 6-O-methylpapyracon B [MeSH Supplementary Concept]
- 6-acetamido-1,1,1-trichloroundecane [MeSH Supplementary Concept]
- 6-methyl-4,4,5-trifluorohept-1,5-dien-3-ol [MeSH Supplementary Concept]
- 7,8-seco-7,8-oxacassa-13,15-diene-7,17-diol [MeSH Supplementary Concept]
- 7alphaH-11-aminogermacra-1(10),4-diene [MeSH Supplementary Concept]
- 8,10,12,14,16-octadecapentaenoic acid [MeSH Supplementary Concept]
- 8,12-iso-isoprostane F2alpha-VI [MeSH Supplementary Concept]
- 8-bromo-beta-phenyl-1,N(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate [MeSH Supplementary Concept]
- 9,13-dicis-retinal [MeSH Supplementary Concept]
- 9-(2-hydroxyethylidene)-cyclopropyl adenine [MeSH Supplementary Concept]
- A 68930 [MeSH Supplementary Concept]
- A 93176 [MeSH Supplementary Concept]
- ACE-ECE-1 dual inhibitor FI [MeSH Supplementary Concept]
- ALRT 1550 [MeSH Supplementary Concept]
- AT 3510 [MeSH Supplementary Concept]
- Atrasentan [MeSH Descriptor]
- B 874-67 [MeSH Supplementary Concept]
- BIBO 3304 [MeSH Supplementary Concept]
- BRL 37344 [MeSH Supplementary Concept]
- BRL 53117 [MeSH Supplementary Concept]
- CB 182 [MeSH Supplementary Concept]
- CB 64D [MeSH Supplementary Concept]
- CEOP protocol 1 [MeSH Supplementary Concept]
- CEV protocol [MeSH Supplementary Concept]
- CGP 56999A [MeSH Supplementary Concept]
- CYN 154806 [MeSH Supplementary Concept]
- E 2011 [MeSH Supplementary Concept]
- EAB 309 [MeSH Supplementary Concept]
- EM 800 [MeSH Supplementary Concept]
- FEC protocol [MeSH Supplementary Concept]
- FPL 12495 [MeSH Supplementary Concept]
- HY 038 [MeSH Supplementary Concept]
- ICI 195739 [MeSH Supplementary Concept]
- Ivabradine [MeSH Descriptor]
- J 114870 [MeSH Supplementary Concept]
- JK 1624F2-1 [MeSH Supplementary Concept]
- KF 17837 [MeSH Supplementary Concept]
- KP372-1 [MeSH Supplementary Concept]
- L 365260 [MeSH Supplementary Concept]
- LU 224332 [MeSH Supplementary Concept]
- LY 306740 [MeSH Supplementary Concept]
- MDL 100173 [MeSH Supplementary Concept]
- MDL 100240 [MeSH Supplementary Concept]
- MDL 105212A [MeSH Supplementary Concept]
- MJ 451 [MeSH Supplementary Concept]
- N-(1-((3-(aminopropyl)-4-(cyclohexylethoxy)phenyl)methyl)-2-hydroxyethyl)-4-((2-methyl-1H-imidazol-1-yl)butyl)benzeneethanamine [MeSH Supplementary Concept]
- N-(2-(4-(2-methoxyphenyl)piperazino)ethyl)-N-2-(pyridyl)-4-fluorocyclohexanecarboxamide [MeSH Supplementary Concept]
- N-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-N,N',N',N'',N''-pentaacetic acid [MeSH Supplementary Concept]
- N-acetyl-4-aminomethyl-6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazole [MeSH Supplementary Concept]
- N-acetyllactosamine-6,6'-disulfate [MeSH Supplementary Concept]
- N-acetylneuraminyl cholesterol [MeSH Supplementary Concept]
- N-dodecoxycarbonylvaline [MeSH Supplementary Concept]
- N-methylcalystegine B3 [MeSH Supplementary Concept]
- N-methylnantradol [MeSH Supplementary Concept]
- N-palmitoylnorleucinol 1-phosphate [MeSH Supplementary Concept]
- NNC 120818 [MeSH Supplementary Concept]
- OEPP protocol [MeSH Supplementary Concept]
- PD 149164 [MeSH Supplementary Concept]
- Phenserine [MeSH Supplementary Concept]
- QW 1624F2-1 [MeSH Supplementary Concept]
- R 84760 [MeSH Supplementary Concept]
- RB 360 [MeSH Supplementary Concept]
- RPI 856 A [MeSH Supplementary Concept]
- RPI 856 C [MeSH Supplementary Concept]
- SAN 202791 [MeSH Supplementary Concept]
- SK 951 [MeSH Supplementary Concept]
- SP 18904 [MeSH Supplementary Concept]
- SQ 27986 [MeSH Supplementary Concept]
- SR 140333 [MeSH Supplementary Concept]
- SRI 62-834 [MeSH Supplementary Concept]
- TEI 9647 [MeSH Supplementary Concept]
- Trp-Lys-Tyr-Met-Val-Met [MeSH Supplementary Concept]
- U 90167 [MeSH Supplementary Concept]
- UCB 35625 [MeSH Supplementary Concept]
- UCT 1072M2 [MeSH Supplementary Concept]
- UK 39671 [MeSH Supplementary Concept]
- VUF 5296 [MeSH Supplementary Concept]
- WP 400 [MeSH Supplementary Concept]
- ZK 805412 [MeSH Supplementary Concept]
- acetyl-norleucyl-aspartyl-histidyl-phenylalanyl-arginyl-beta-methyltryptophyl-lysinamide, cyclic (2-7)-peptide [MeSH Supplementary Concept]
- adenosine-3',5'-cyclic phosphorothioate [MeSH Supplementary Concept]
- aglinin A [MeSH Supplementary Concept]
- albaconazole [MeSH Supplementary Concept]
- allopregnane-3,20-diol [MeSH Supplementary Concept]
- alpha-(E)-acaridiol 8-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- alpha-solamargine [MeSH Supplementary Concept]
- ampullicin [MeSH Supplementary Concept]
- ancistroguineine A [MeSH Supplementary Concept]
- andrographolide [MeSH Supplementary Concept]
- angoroside C [MeSH Supplementary Concept]
- annomuricin A [MeSH Supplementary Concept]
- aplykurodinone B [MeSH Supplementary Concept]
- arenophthalide B [MeSH Supplementary Concept]
- asprellic acid A [MeSH Supplementary Concept]
- astilbin [MeSH Supplementary Concept]
- astragaloside A [MeSH Supplementary Concept]
- balanitol [MeSH Supplementary Concept]
- bay Q 3111 [MeSH Supplementary Concept]
- beta-isocryptoxanthin [MeSH Supplementary Concept]
- bioallethrin [MeSH Supplementary Concept]
- bistramide C [MeSH Supplementary Concept]
- biteuvisone A [MeSH Supplementary Concept]
- bombinin H2 [MeSH Supplementary Concept]
- breviflavone A [MeSH Supplementary Concept]
- brucojavan 2 [MeSH Supplementary Concept]
- bullatacinone [MeSH Supplementary Concept]
- calamenene [MeSH Supplementary Concept]
- callistiviminene A [MeSH Supplementary Concept]
- castanospermine [MeSH Supplementary Concept]
- castasterone [MeSH Supplementary Concept]
- cellulose tris(phenylpropionate) [MeSH Supplementary Concept]
- cerivastatin [MeSH Supplementary Concept]
- chatancin [MeSH Supplementary Concept]
- ciliatamide A [MeSH Supplementary Concept]
- cinnamtannin B-1 [MeSH Supplementary Concept]
- citrinadin A [MeSH Supplementary Concept]
- colletodiol [MeSH Supplementary Concept]
- conicol [MeSH Supplementary Concept]
- corallidictyal A [MeSH Supplementary Concept]
- cordatolide A [MeSH Supplementary Concept]
- costunolide [MeSH Supplementary Concept]
- cryptophycin 326 [MeSH Supplementary Concept]
- cyanofluoro-p-tolylacetic acid [MeSH Supplementary Concept]
- cyclic-tris-(R)-valineselenazole [MeSH Supplementary Concept]
- cyclo(cysteinyl-glutaminyl-isoleucyl-tryptophyl-lysyl-glutaminyl-lysyl-prolyl-aspartyl-leucyl-cysteinyl-amide) [MeSH Supplementary Concept]
- dehydroerythorbic acid [MeSH Supplementary Concept]
- desacetylnantradol [MeSH Supplementary Concept]
- dexamisole [MeSH Supplementary Concept]
- dexchlorpheniramine [MeSH Supplementary Concept]
- dexivacain [MeSH Supplementary Concept]
- dexphenmetrazine [MeSH Supplementary Concept]
- dextrallorphan [MeSH Supplementary Concept]
- dextramycine [MeSH Supplementary Concept]
- dextronorgestrel [MeSH Supplementary Concept]
- dihydrolyfoline [MeSH Supplementary Concept]
- dilactide [MeSH Supplementary Concept]
- diolmycin A1 [MeSH Supplementary Concept]
- distomadine A [MeSH Supplementary Concept]
- dodecyl urocanate [MeSH Supplementary Concept]
- eilatine [MeSH Supplementary Concept]
- elaidic acid [MeSH Supplementary Concept]
- ent-4-desacetoxy-6,7-dihydrovindorosine [MeSH Supplementary Concept]
- epiaustraline [MeSH Supplementary Concept]
- epiyangambin [MeSH Supplementary Concept]
- erinaceolactone G [MeSH Supplementary Concept]
- ethyl 3-hydroxybutyrate [MeSH Supplementary Concept]
- eucatex [MeSH Supplementary Concept]
- fazarabine [MeSH Supplementary Concept]
- felixinin [MeSH Supplementary Concept]
- ferruginine [MeSH Supplementary Concept]
- fujianmycin B [MeSH Supplementary Concept]
- gabosine N [MeSH Supplementary Concept]
- gabosine O [MeSH Supplementary Concept]
- gallicadiol [MeSH Supplementary Concept]
- gelliusine A [MeSH Supplementary Concept]
- ginsenoside R10 [MeSH Supplementary Concept]
- glabracin A [MeSH Supplementary Concept]
- glutathione-BPDE conjugate [MeSH Supplementary Concept]
- goniodomin A [MeSH Supplementary Concept]
- growth hormone releasing hexapeptide [MeSH Supplementary Concept]
- gymnomitrene [MeSH Supplementary Concept]
- gypenbioside A [MeSH Supplementary Concept]
- hexadecenoic acid [MeSH Supplementary Concept]
- hexahydrofuro(2,3-b)furan-3-ol [MeSH Supplementary Concept]
- homosenkyunolide H [MeSH Supplementary Concept]
- hyacinthacine A1 [MeSH Supplementary Concept]
- illudin C2 [MeSH Supplementary Concept]
- inositol-1,3,4,6-tetrakisphosphate [MeSH Supplementary Concept]
- iridolactone [MeSH Supplementary Concept]
- isoascorbic acid [MeSH Supplementary Concept]
- isomyrmicarin 430B [MeSH Supplementary Concept]
- isonuatigenone [MeSH Supplementary Concept]
- isopimaric acid [MeSH Supplementary Concept]
- isosilybin A [MeSH Supplementary Concept]
- isotsaokoin [MeSH Supplementary Concept]
- kalimantacin A [MeSH Supplementary Concept]
- kenposide A [MeSH Supplementary Concept]
- komaroviquinone [MeSH Supplementary Concept]
- korupensamine A [MeSH Supplementary Concept]
- kosinostatin [MeSH Supplementary Concept]
- kotomolide A [MeSH Supplementary Concept]
- kurziflavolactone A [MeSH Supplementary Concept]
- lamiridosin A [MeSH Supplementary Concept]
- lasubin I [MeSH Supplementary Concept]
- leucyl-glycyl-threonyl-phenylalanyl-leucyl-lysyl-cysteine [MeSH Supplementary Concept]
- levomoramide [MeSH Supplementary Concept]
- loganic acid [MeSH Supplementary Concept]
- lucidulactone A [MeSH Supplementary Concept]
- macrophylline A [MeSH Supplementary Concept]
- madindoline A [MeSH Supplementary Concept]
- malyngamide C [MeSH Supplementary Concept]
- manassantin B [MeSH Supplementary Concept]
- maslinic acid [MeSH Supplementary Concept]
- mattucinol-7-O-(4'',6''-O-(aS)-hexahydroxydiphenoyl)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- melicolone A [MeSH Supplementary Concept]
- merrilactone A [MeSH Supplementary Concept]
- methyl 2,3,4,6-tetra-O-benzoyl-alpha-D-glucopyranoside [MeSH Supplementary Concept]
- methyl 27-O-caffeoylcylicodiscate [MeSH Supplementary Concept]
- michellamine A [MeSH Supplementary Concept]
- mitraphyllic acid [MeSH Supplementary Concept]
- muricatocin A [MeSH Supplementary Concept]
- murisolin [MeSH Supplementary Concept]
- mycestericin D [MeSH Supplementary Concept]
- mycestericin F [MeSH Supplementary Concept]
- nantradol [MeSH Supplementary Concept]
- neo-kyotorphin [MeSH Supplementary Concept]
- neoisoliquiritin [MeSH Supplementary Concept]
- neopuerarin A [MeSH Supplementary Concept]
- neovibsanin A [MeSH Supplementary Concept]
- neurotensin, Tyr(11)- [MeSH Supplementary Concept]
- nitraramine [MeSH Supplementary Concept]
- nordhagenine B [MeSH Supplementary Concept]
- nutlin 3 [MeSH Supplementary Concept]
- ocobullenone [MeSH Supplementary Concept]
- org 13061 [MeSH Supplementary Concept]
- p-bromomethylphenidate [MeSH Supplementary Concept]
- p-methoxymethylphenidate [MeSH Supplementary Concept]
- palau'amine [MeSH Supplementary Concept]
- pallavicinin [MeSH Supplementary Concept]
- palmyrolide A [MeSH Supplementary Concept]
- pandangolide 1 [MeSH Supplementary Concept]
- panudial [MeSH Supplementary Concept]
- pedicularis-lactone [MeSH Supplementary Concept]
- penigequinolone A [MeSH Supplementary Concept]
- pentisomicin [MeSH Supplementary Concept]
- petasin [MeSH Supplementary Concept]
- phenanthrene tetraol [MeSH Supplementary Concept]
- phenylpropylene oxide [MeSH Supplementary Concept]
- pinidinol [MeSH Supplementary Concept]
- placidene A [MeSH Supplementary Concept]
- presphaerene [MeSH Supplementary Concept]
- procurcumenol [MeSH Supplementary Concept]
- pseudococaine [MeSH Supplementary Concept]
- pycnanthuquinone A [MeSH Supplementary Concept]
- pyridinopyrone B [MeSH Supplementary Concept]
- ranirestat [MeSH Supplementary Concept]
- repaglinide [MeSH Supplementary Concept]
- rigidiusculamide A [MeSH Supplementary Concept]
- rugulotrosin A [MeSH Supplementary Concept]
- saccharomicin A [MeSH Supplementary Concept]
- salcolin A [MeSH Supplementary Concept]
- sanggenone C [MeSH Supplementary Concept]
- sanionin A [MeSH Supplementary Concept]
- saudin [MeSH Supplementary Concept]
- sch 59228 [MeSH Supplementary Concept]
- schisdilactone H [MeSH Supplementary Concept]
- schizanthine N [MeSH Supplementary Concept]
- scuteflorin A [MeSH Supplementary Concept]
- scyllitol [MeSH Supplementary Concept]
- secaloside A [MeSH Supplementary Concept]
- secaloside C [MeSH Supplementary Concept]
- securinine [MeSH Supplementary Concept]
- siastatin [MeSH Supplementary Concept]
- solanapyrone A [MeSH Supplementary Concept]
- solanapyrone B [MeSH Supplementary Concept]
- somatostatin, octapeptide-Trp(8)- [MeSH Supplementary Concept]
- sparoxomycin A1 [MeSH Supplementary Concept]
- spirooliganone A [MeSH Supplementary Concept]
- sporolide A [MeSH Supplementary Concept]
- stemonamide [MeSH Supplementary Concept]
- strigol [MeSH Supplementary Concept]
- strobilinin [MeSH Supplementary Concept]
- sulfoxaflor [MeSH Supplementary Concept]
- suspensoside A [MeSH Supplementary Concept]
- syn-3,4-seco-12R-hydroxy-15,16-epoxy-4(18),8(17),13(16),14(15)-labdatetraen-3-oic acid [MeSH Supplementary Concept]
- tenuecyclamide A [MeSH Supplementary Concept]
- terricollene A [MeSH Supplementary Concept]
- testudinariol A [MeSH Supplementary Concept]
- tofisopam [MeSH Supplementary Concept]
- trans-11,12-Dihydroxy-11,12-dihydrodibenzo(a,l)pyrene [MeSH Supplementary Concept]
- trans-dimer D, axinyssa variabilis [MeSH Supplementary Concept]
- transplatin [MeSH Supplementary Concept]
- tribufuroside D [MeSH Supplementary Concept]
- triumphalone [MeSH Supplementary Concept]
- tylopilusin A [MeSH Supplementary Concept]
- vamicamide [MeSH Supplementary Concept]
- vialinin A [MeSH Supplementary Concept]
- wasalexin A [MeSH Supplementary Concept]
- xanalteric acid I [MeSH Supplementary Concept]
- zacopride [MeSH Supplementary Concept]
- zampanolide [MeSH Supplementary Concept]
Record concept(s)
- molecular stereochemistry [MeSH concept]
- stereoisomerism [MeSH concept]
- stereoisomers [MeSH concept]
Semantic type(s)
- Natural Phenomenon or Process [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients